American Funds Capital World Growth and Income Fund® Class R-4 (RWIEX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
63.15
-0.30 (-0.47%)
Dec 19, 2024, 4:00 PM EST
6.17% (1Y)
Fund Assets | 128.05B |
Expense Ratio | 0.76% |
Min. Investment | $250 |
Turnover | 27.00% |
Dividend (ttm) | 4.99 |
Dividend Yield | 7.87% |
Dividend Growth | 143.77% |
Payout Frequency | Quarterly |
Ex-Dividend Date | Dec 17, 2024 |
Previous Close | 63.45 |
YTD Return | 13.46% |
1-Year Return | 14.34% |
5-Year Return | 50.98% |
52-Week Low | 58.73 |
52-Week High | 69.93 |
Beta (5Y) | n/a |
Holdings | 323 |
Inception Date | Jun 27, 2002 |
About RWIEX
The fund invests primarily in common stocks of well-established companies located around the world, many of which have the potential to pay dividends. It invests, on a global basis, in common stocks that are denominated in U.S. dollars or other currencies. Under normal market circumstances the fund will invest a significant portion of its assets in a number of countries outside the United States, including in developing countries.
Fund Family American Funds
Category World Large-Stock Blend
Performance Rating Average
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol RWIEX
Index MSCI AC World NR USD
Top 10 Holdings
24.78% of assetsName | Symbol | Weight |
---|---|---|
Broadcom Inc. | AVGO | 3.90% |
Capital Group Central Cash Fund | n/a | 3.84% |
Microsoft Corporation | MSFT | 3.57% |
Taiwan Semiconductor Manufacturing Company Limited | 2330 | 3.34% |
Apple Inc. | AAPL | 2.10% |
Philip Morris International Inc. | PM | 1.74% |
Eli Lilly and Company | LLY | 1.74% |
UnitedHealth Group Incorporated | UNH | 1.57% |
General Electric Company | GE | 1.55% |
Meta Platforms, Inc. | META | 1.42% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 17, 2024 | $4.2548 | Dec 18, 2024 |
Sep 16, 2024 | $0.1953 | Sep 17, 2024 |
Jun 10, 2024 | $0.3464 | Jun 11, 2024 |
Mar 11, 2024 | $0.1984 | Mar 12, 2024 |
Dec 12, 2023 | $1.3037 | Dec 13, 2023 |
Sep 11, 2023 | $0.1986 | Sep 12, 2023 |